These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 26111701)
1. Mechanisms underlying clinical efficacy of Angiotensin II type 2 receptor (AT2R) antagonist EMA401 in neuropathic pain: clinical tissue and in vitro studies. Anand U; Yiangou Y; Sinisi M; Fox M; MacQuillan A; Quick T; Korchev YE; Bountra C; McCarthy T; Anand P Mol Pain; 2015 Jun; 11():38. PubMed ID: 26111701 [TBL] [Abstract][Full Text] [Related]
2. Angiotensin II type 2 receptor (AT2 R) localization and antagonist-mediated inhibition of capsaicin responses and neurite outgrowth in human and rat sensory neurons. Anand U; Facer P; Yiangou Y; Sinisi M; Fox M; McCarthy T; Bountra C; Korchev YE; Anand P Eur J Pain; 2013 Aug; 17(7):1012-26. PubMed ID: 23255326 [TBL] [Abstract][Full Text] [Related]
3. A small molecule angiotensin II type 2 receptor (AT₂R) antagonist produces analgesia in a rat model of neuropathic pain by inhibition of p38 mitogen-activated protein kinase (MAPK) and p44/p42 MAPK activation in the dorsal root ganglia. Smith MT; Woodruff TM; Wyse BD; Muralidharan A; Walther T Pain Med; 2013 Oct; 14(10):1557-68. PubMed ID: 23742186 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of the angiotensin II type 2 receptor AT Perryman R; Renziehausen A; Shaye H; Kostagianni AD; Tsiailanis AD; Thorne T; Chatziathanasiadou MV; Sivolapenko GB; El Mubarak MA; Han GW; Zarzycka B; Katritch V; Lebon G; Lo Nigro C; Lattanzio L; Morse SV; Choi JJ; O'Neill K; Kanaki Z; Klinakis A; Crook T; Cherezov V; Tzakos AG; Syed N Proc Natl Acad Sci U S A; 2022 Aug; 119(32):e2116289119. PubMed ID: 35917342 [TBL] [Abstract][Full Text] [Related]
5. Analgesic efficacy and mode of action of a selective small molecule angiotensin II type 2 receptor antagonist in a rat model of prostate cancer-induced bone pain. Muralidharan A; Wyse BD; Smith MT Pain Med; 2014 Jan; 15(1):93-110. PubMed ID: 24433468 [TBL] [Abstract][Full Text] [Related]
6. Mycolactone-mediated neurite degeneration and functional effects in cultured human and rat DRG neurons: Mechanisms underlying hypoalgesia in Buruli ulcer. Anand U; Sinisi M; Fox M; MacQuillan A; Quick T; Korchev Y; Bountra C; McCarthy T; Anand P Mol Pain; 2016; 12():. PubMed ID: 27325560 [TBL] [Abstract][Full Text] [Related]
7. Angiotensin II type 2-receptor: new clinically validated target in the treatment of neuropathic pain. Rice AS; Smith MT Clin Pharmacol Ther; 2015 Feb; 97(2):128-30. PubMed ID: 25670516 [TBL] [Abstract][Full Text] [Related]
8. Targeting angiotensin II type 2 receptor pathways to treat neuropathic pain and inflammatory pain. Smith MT; Muralidharan A Expert Opin Ther Targets; 2015 Jan; 19(1):25-35. PubMed ID: 25315162 [TBL] [Abstract][Full Text] [Related]
9. TRPA1 receptor localisation in the human peripheral nervous system and functional studies in cultured human and rat sensory neurons. Anand U; Otto WR; Facer P; Zebda N; Selmer I; Gunthorpe MJ; Chessell IP; Sinisi M; Birch R; Anand P Neurosci Lett; 2008 Jun; 438(2):221-7. PubMed ID: 18456404 [TBL] [Abstract][Full Text] [Related]
10. EMA401, an orally administered highly selective angiotensin II type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: a randomised, double-blind, placebo-controlled phase 2 clinical trial. Rice ASC; Dworkin RH; McCarthy TD; Anand P; Bountra C; McCloud PI; Hill J; Cutter G; Kitson G; Desem N; Raff M; Lancet; 2014 May; 383(9929):1637-1647. PubMed ID: 24507377 [TBL] [Abstract][Full Text] [Related]
12. Differential expression of the capsaicin receptor TRPV1 and related novel receptors TRPV3, TRPV4 and TRPM8 in normal human tissues and changes in traumatic and diabetic neuropathy. Facer P; Casula MA; Smith GD; Benham CD; Chessell IP; Bountra C; Sinisi M; Birch R; Anand P BMC Neurol; 2007 May; 7():11. PubMed ID: 17521436 [TBL] [Abstract][Full Text] [Related]
13. Comparative functional properties of two structurally similar selective nonpeptide drug-like ligands for the angiotensin II type-2 (AT(2)) receptor. Effects on neurite outgrowth in NG108-15 cells. Guimond MO; Wallinder C; Alterman M; Hallberg A; Gallo-Payet N Eur J Pharmacol; 2013 Jan; 699(1-3):160-71. PubMed ID: 23211679 [TBL] [Abstract][Full Text] [Related]
15. Relative affinity of angiotensin peptides and novel ligands at AT1 and AT2 receptors. Bosnyak S; Jones ES; Christopoulos A; Aguilar MI; Thomas WG; Widdop RE Clin Sci (Lond); 2011 Oct; 121(7):297-303. PubMed ID: 21542804 [TBL] [Abstract][Full Text] [Related]
16. Reduced sensitivity of the renal vasculature to angiotensin II in young rats: the role of the angiotensin type 2 receptor. Brown RD; Hilliard LM; Mirabito KM; Wirth LC; Moritz KM; Evans RG; Denton KM Pediatr Res; 2014 Nov; 76(5):448-52. PubMed ID: 25119338 [TBL] [Abstract][Full Text] [Related]
17. EMA401, an angiotensin II type 2 receptor antagonist blocks visceral hypersensitivity and colonic hyperpermeability in rat model of irritable bowel syndrome. Nozu T; Miyagishi S; Nozu R; Ishioh M; Takakusaki K; Okumura T J Pharmacol Sci; 2021 Jul; 146(3):121-124. PubMed ID: 34030794 [TBL] [Abstract][Full Text] [Related]